Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression*

14-3-3 sigma, implicated in cell cycle arrest by p53, was cloned by expression cloning through cyclin-dependent kinase 2 (CDK2) association. 14-3-3 sigma shares cyclin-CDK2 binding motifs with different cell cycle regulators, including p107, p130, p21CIP1, p27KIP1, and p57KIP2, and is associated with cyclin·CDK complexesin vitro and in vivo. Overexpression of 14-3-3 sigma obstructs cell cycle entry by inhibiting cyclin-CDK activity in many breast cancer cell lines. Overexpression of 14-3-3 sigma can also inhibit cell proliferation and prevent anchorage-independent growth of these cell lines. These findings define 14-3-3 sigma as a negative regulator of the cell cycle progression and suggest that it has an important function in preventing breast tumor cell growth.

[1]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[2]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[3]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[4]  C. O'keefe,et al.  Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4. , 1996, Molecular biology of the cell.

[5]  C. Turck,et al.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.

[6]  S. Moreno,et al.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 , 1998, Nature.

[7]  E. Valverius,et al.  Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[8]  H. Kung,et al.  Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells , 1998, Nature.

[9]  M. Yaffe,et al.  The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.

[10]  N. Walworth,et al.  Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage. , 1999, Genes & development.

[11]  Philip D. Jeffrey,et al.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.

[12]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[13]  A. Aitken,et al.  14-3-3 proteins : a highly conserved widespread family of eukaryotic proteins , 2003 .

[14]  M. Reiss,et al.  Cloning of putative growth regulatory genes from primary human keratinocytes by subtractive hybridization. , 1995, Gene.

[15]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[16]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[17]  S. Elledge,et al.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.

[18]  P. Russell,et al.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein , 1999, Nature.

[19]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[20]  A. Ullrich,et al.  High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Carr,et al.  14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast. , 1994, Science.

[22]  James M. Roberts,et al.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.

[23]  S. Elledge,et al.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.

[24]  W. Kolch,et al.  Regulation of Raf‐1 kinase activity by the 14‐3‐3 family of proteins. , 1995, The EMBO journal.

[25]  E. Dellambra,et al.  Stratifin, a keratinocyte specific 14-3-3 protein, harbors a pleckstrin homology (PH) domain and enhances protein kinase C activity. , 1995, Journal of cell science.

[26]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[27]  R. Honda,et al.  14-3-3 zeta protein binds to the carboxyl half of mouse wee1 kinase. , 1997, Biochemical and biophysical research communications.

[28]  Peggy J. Farnham,et al.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties , 1992, Cell.

[29]  J. Pines.  Cell cycle: Checkpoint on the nuclear frontier , 1999, Nature.

[30]  W. Fantl,et al.  Activation of Raf-1 by 14-3-3 proteins , 1994, Nature.

[31]  D. Beach,et al.  14-3-3 proteins associate with cdc25 phosphatases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[33]  F. Sladeczek,et al.  The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins , 1997, Molecular and General Genetics MGG.

[34]  R. Hruban,et al.  High‐resolution deletion mapping of chromosome arm 1p in pancreatic cancer identifies a major consensus region at 1p35 , 1999, Genes, chromosomes & cancer.

[35]  Herman Yeger,et al.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer , 1997, Nature Medicine.

[36]  T. Roberts,et al.  Association of polyomavirus middle tumor antigen with 14-3-3 proteins. , 1994, Science.

[37]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[38]  C. Peng,et al.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. , 1997, Science.

[39]  P. Allen,et al.  Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.

[40]  J. Jónasson,et al.  Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival , 1999, British Journal of Cancer.

[41]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[42]  C. O'keefe,et al.  Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.

[43]  D. Morgan,et al.  Activation of human cyclin-dependent kinases in vitro. , 1992, Molecular biology of the cell.

[44]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.